-
News Agency News Aggregator Journalist/Editor Broking House Others
BAFNAPHARM - Board Meeting Outcome for Outcome Of Board Meeting Held On 16Th Sep 2021
BAFNAPHARM - Board Meeting Intimation for Proposal Of Availing Working Capital / Term Loan Facility For Expansion Program
BAFNAPHARM - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
BAFNAPHARM - Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
BAFNAPHARM - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Bafna Pharma posts higher Q1 profit of Rs208.70 lakhs on export deliveries #bafnapharma
Bafna Pharma Posts INR 208.70 Lakhs Profit in Q1 #BafnaPharma
#BAFNAPHARM BAFNA PHARMACEUTICALS RESULT
BAFNAPHARM - Q1 2021-22 Results
Bafna Pharmaceuticals Ltd Q1FY22 PAT slips QoQ to Rs. 2.08 crore #BafnaPharmaceuticals #Q1FY22 #ResultUpdate
BAFNAPHARM - Board Meeting Outcome for Outcome Of The Board Meeting Held On 05Th August 2021
BAFNAPHARM - Board Meeting Intimation for Intimation Of Board Meeting Of The Company To Inter-Alia Consider And Approve The Un-Audited #Part1
#BAFNAPHARM BAFNA PH RESULT GOOD
BAFNAPHARM - Discrepancies In Standalone Financial Results
BAFNAPHARM - Book Closure For The Purpose Of Annual General Meeting
BAFNAPHARM - Reg. 34 (1) Annual Report
Angel Broking, Bafna Pharmaceuticals, Kanpur Plastipack, Goodluck India, Capital Trust, 5paisa Capital, Parsvnath Developers and Infomedia Press were among those 500-odd stocks that hit their upper circuits in intraday trade on BSE.
BAFNAPHARM - Statement Of Investor Complaints For The Quarter Ended June 2021
BAFNAPHARM - Sub.:- Disclosure Under Regulation 23(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - #Part1
Bafna Pharmaceuticals Ltd Q4 PAT rises to Rs. 2.63 crore #Q4FY21 #FY2021 #ResultUpdate
-
Connect with us on social media
